Recombinant factor VIIa treatment of severe bleeding in cardiac surgery patients: a retrospective analysis of dosing, efficacy, and safety outcomes.


OBJECTIVE To describe rFVIIa dosing and clinical outcomes in cardiovascular surgery patients with refractory bleeding. DESIGN Retrospective chart review of patients receiving rFVIIa from January 1, 2004 to September 30, 2005, in the cardiovascular surgery setting. SETTING Tertiary care, private teaching hospital. PARTICIPANTS Ninety-three patients who… (More)
DOI: 10.1053/j.jvca.2008.08.003